Search research articles
Contact Us
Filters
Showing results (401-410 of 531) with videos related to
Page
of 54
Sort By:
JAMA Oncology
|
February 10, 2018
Association of Sulindac and Erlotinib vs Placebo With Colorectal Neoplasia in Familial Adenomatous Polyposis: Secondary Analysis of a Randomized Clinical Trial
N Jewel Samadder, Scott K Kuwada, Kenneth M Boucher, et al.
Neuro-Oncology Practice
|
May 15, 2023
Clinical outcome following surgical resection and radiotherapy in adult patients with pleomorphic xanthoastrocytoma as defined by DNA methylation profiling
Maximilian Deng, Felix Hinz, Semi Harrabi, et al.
Thorax
|
February 27, 2025
Six early CPAP-usage behavioural patterns determine peak CPAP adherence and permit tailored intervention, in patients with obstructive sleep apnoea
Julia Dielesen, Lesedi J Ledwaba-Chapman, Pragna Kasetti, et al.
Radiology
|
September 17, 2016
Radiogenomics of Glioblastoma: Machine Learning-based Classification of Molecular Characteristics by Using Multiparametric and Multiregional MR Imaging Features
Philipp Kickingereder, David Bonekamp, Martha Nowosielski, et al.
JHEP Reports : Innovation in Hepatology
|
August 14, 2025
Implementation of a care bundle improves PBC management
Rachel Smith, Laura Burke, Nadir Abbas, et al.
Hepatology (Baltimore, Md.)
|
October 13, 2017
A randomized trial of obeticholic acid monotherapy in patients with primary biliary cholangitis
Kris V Kowdley, Velimir Luketic, Roger Chapman, et al.
Research Evaluation
|
May 9, 2014
Measuring the evolution and output of cross-disciplinary collaborations within the NCI Physical Sciences-Oncology Centers Network
Jodi E Basner, Katrina I Theisz, Unni S Jensen, et al.
Journal of Hepatology
|
January 23, 2021
A randomized placebo-controlled trial of elafibranor in patients with primary biliary cholangitis and incomplete response to UDCA
Jörn M Schattenberg, Albert Pares, Kris V Kowdley, et al.
Human Molecular Genetics
|
June 2, 2021
PAK1 inhibition reduces tumor size and extends the lifespan of mice in a genetically engineered mouse model of Neurofibromatosis Type 2 (NF2)
Eric Hawley, Jeffrey Gehlhausen, Sofiia Karchugina, et al.
Nature Communications
|
October 3, 2019
Framework engineering to produce dominant T cell receptors with enhanced antigen-specific function
Sharyn Thomas, Fiyaz Mohammed, Rogier M Reijmers, et al.
Page
of 54
Search research articles
Search
Showing results (401-410 of 531) with videos related to
Sort By:
Page
of 54
JAMA Oncology
|
February 10, 2018
Association of Sulindac and Erlotinib vs Placebo With Colorectal Neoplasia in Familial Adenomatous Polyposis: Secondary Analysis of a Randomized Clinical Trial
N Jewel Samadder, Scott K Kuwada, Kenneth M Boucher, et al.
Neuro-Oncology Practice
|
May 15, 2023
Clinical outcome following surgical resection and radiotherapy in adult patients with pleomorphic xanthoastrocytoma as defined by DNA methylation profiling
Maximilian Deng, Felix Hinz, Semi Harrabi, et al.
Thorax
|
February 27, 2025
Six early CPAP-usage behavioural patterns determine peak CPAP adherence and permit tailored intervention, in patients with obstructive sleep apnoea
Julia Dielesen, Lesedi J Ledwaba-Chapman, Pragna Kasetti, et al.
Radiology
|
September 17, 2016
Radiogenomics of Glioblastoma: Machine Learning-based Classification of Molecular Characteristics by Using Multiparametric and Multiregional MR Imaging Features
Philipp Kickingereder, David Bonekamp, Martha Nowosielski, et al.
JHEP Reports : Innovation in Hepatology
|
August 14, 2025
Implementation of a care bundle improves PBC management
Rachel Smith, Laura Burke, Nadir Abbas, et al.
Hepatology (Baltimore, Md.)
|
October 13, 2017
A randomized trial of obeticholic acid monotherapy in patients with primary biliary cholangitis
Kris V Kowdley, Velimir Luketic, Roger Chapman, et al.
Research Evaluation
|
May 9, 2014
Measuring the evolution and output of cross-disciplinary collaborations within the NCI Physical Sciences-Oncology Centers Network
Jodi E Basner, Katrina I Theisz, Unni S Jensen, et al.
Journal of Hepatology
|
January 23, 2021
A randomized placebo-controlled trial of elafibranor in patients with primary biliary cholangitis and incomplete response to UDCA
Jörn M Schattenberg, Albert Pares, Kris V Kowdley, et al.
Human Molecular Genetics
|
June 2, 2021
PAK1 inhibition reduces tumor size and extends the lifespan of mice in a genetically engineered mouse model of Neurofibromatosis Type 2 (NF2)
Eric Hawley, Jeffrey Gehlhausen, Sofiia Karchugina, et al.
Nature Communications
|
October 3, 2019
Framework engineering to produce dominant T cell receptors with enhanced antigen-specific function
Sharyn Thomas, Fiyaz Mohammed, Rogier M Reijmers, et al.
Page
of 54